Metonitazene
|
Metonitazene
N,N-diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1H-benzo[d]imidazol-1-yl)ethan-1-amine |
|
| N,N-diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1H-benzo[d]imidazol-1-yl)ethan-1-amine | |
| Nitazenes | |
| Synthetic opioids |
|
|
|
InChI=1S/C21H26N4O3/c1-4-23(5-2)12-13-24-20-11-8-17(25(26)27)15-19(20)22-21(24)14-16-6-9-18(28-3)10-7-16/h6-11,15H,4-5,12-14H2,1-3H3
|
|
HNGZTLMRQTVPBH-UHFFFAOYSA-N
|
|
|
O=[N+](C1=CC=C2C(N=C(CC3=CC=C(OC)C=C3)N2CCN(CC)CC)=C1)[O-]
|
|
| C21H26N4O3 | |
| 382.4561 g/mol | |
| 61/I | |
| 2022 | |
|
This substance is included in Schedule I of the 1961 Single Convention on Narcotic Drugs.
|